CAGNACCI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 10.663
EU - Europa 1.917
AS - Asia 686
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 6
AF - Africa 3
OC - Oceania 2
Totale 13.297
Nazione #
US - Stati Uniti d'America 10.656
UA - Ucraina 751
CN - Cina 377
SE - Svezia 342
DE - Germania 308
TR - Turchia 229
IE - Irlanda 153
IT - Italia 135
FI - Finlandia 75
GB - Regno Unito 53
VN - Vietnam 45
RU - Federazione Russa 34
EU - Europa 20
BE - Belgio 15
RS - Serbia 12
KR - Corea 11
FR - Francia 8
AT - Austria 7
HK - Hong Kong 7
NL - Olanda 7
CA - Canada 6
IN - India 5
CO - Colombia 4
ES - Italia 4
JP - Giappone 4
PH - Filippine 4
PL - Polonia 4
RO - Romania 3
AU - Australia 2
IL - Israele 2
TG - Togo 2
BR - Brasile 1
CL - Cile 1
EE - Estonia 1
IM - Isola di Man 1
IR - Iran 1
LT - Lituania 1
MD - Moldavia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
TN - Tunisia 1
Totale 13.297
Città #
Fairfield 1.776
Woodbridge 1.286
Houston 888
Ashburn 855
Chandler 848
Seattle 724
Wilmington 632
Cambridge 604
Ann Arbor 572
Dearborn 395
Jacksonville 357
Izmir 229
Beijing 169
Princeton 156
Dublin 153
Des Moines 127
Boardman 78
San Diego 77
Dong Ket 45
Falls Church 42
Hefei 30
New York 30
Saint Petersburg 30
Udine 30
Norwalk 29
Ogden 27
Kunming 26
Nanjing 24
Guangzhou 19
Grafing 17
Milan 17
Venezia 16
Brussels 15
Fuzhou 13
Belgrade 12
Jinan 11
Nanchang 11
Redmond 11
Tappahannock 9
Hebei 8
Chongqing 7
Gwangju 7
Phoenix 7
Redwood City 7
Zhengzhou 7
Hong Kong 6
Ningbo 6
Verona 6
Chengdu 5
Toronto 5
Vigevano 5
Indiana 4
Palmanova 4
Shenyang 4
Vienna 4
Genova 3
Jiaxing 3
Pignone 3
Rome 3
Sankt Pölten 3
Sasebo 3
Warsaw 3
Xian 3
Zaragoza 3
Amsterdam 2
Andover 2
Bogotá 2
Changsha 2
Chernivtsi 2
Chicago 2
Cologne 2
Dallas 2
Edinburgh 2
Frankfurt am Main 2
Hertford 2
Iloilo City 2
Lomé 2
Nanning 2
Pompiano 2
Pune 2
San Mateo 2
Tel Aviv 2
Turin 2
Venice 2
Vercelli 2
Washington 2
Wenzhou 2
Wuhan 2
Ardabil 1
Atlanta 1
Augusta 1
Baotou 1
Bari 1
Baricella 1
Ben Arous 1
Bologna 1
Bovisio Masciago 1
Brisbane 1
Bucharest 1
Carrù 1
Totale 10.569
Nome #
Female sexuality and vaginal health across the menopausal age 332
Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. 204
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 160
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 146
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 146
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 143
Regulation of the 24h body temperature rhythm of women in luteal phase: role of gonadal steroids and prostaglandins. 142
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 140
Massive Hemoperitoneum from Uterine Leiomyoma Associated with Diffuse Myometrial Venous Congestion 139
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 133
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 132
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 132
Intermenstrual pelvic pain, quality of life and mood 118
Adenomyosis of the Extrapelvic Portion of the Round Ligament 117
Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthase in postmenopausal women 117
Role of melatonin in circadian rhythm at menopause 113
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 113
Increased cortisol level: a possible link between climacteric symptoms and cardiovascular risk factors. 112
Prevalence of menstrual pain in young women: what is dysmenorrhea 112
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 112
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 112
Association between pelvic organ prolapse and climacteric symptoms in postmenopausal women 110
Influences of maternal weight on the secondary sex ratio of human offspring 108
Chronic pelvic pain improvement: impact on quality of life and mood 108
European society of contraception statement on contraception in obese women 106
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function. 106
Hormone replacement therapy and prevention of chronic conditions 106
Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study 106
Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebo-controlled study. 105
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 105
Folate administration decreases oxidative status and blood pressure in postmenopausal women 105
Sexual dimorphism in the levels of amniotic fluid leptin in pregnancies at 16 weeks of gestation 105
Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis 104
Bleeding profile in users of an etonogestrel sub-dermal implant: Effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population 104
Hormonal contraception: venous and arterial disease 103
Management of vaginal atrophy: a real mess. Results from the AGATA study 103
Association between urinary incontinence and climacteric symptoms in postmenopausal women 103
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 103
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 102
Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome 102
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 101
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group (.) 101
History of vasomotor symptoms, extent of coronary artery disease, and clinical outcomes after acute coronary syndrome in postmenopausal women 101
Effects of low- or high-dose hormone therapy on fasting and post-methionine homocysteine levels in postmenopausal women 100
Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women. 100
Dienogest mediates midkine suppression in endometriosis 100
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 100
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 99
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 99
Reply to: Interactions BetweenMelatonin and Estrogen in the Regulation of Blood Pressure 99
A comparison of the central effects of different progestins used in hormone replacement therapy 99
Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy 98
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 98
Raloxifene does not modify insulin sensitivity and glucose metabolism in postmenopausal women. 97
Different circulatory response to melatonin in postmenopausal women without and with hormone replacement therapy 97
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. 96
Course of primary headaches during hormone replacement therapy 96
Prolonged melatonin administration decreases nocturnal blood pressure in women. 95
Pharmacokinetic evaluation of desogestrel as a female contraceptive 95
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 95
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 95
Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women 94
Intensity of menstrual pain and estimated angle of uterine flexion 94
Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: a case-control study 94
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 94
Metabolic impact of combined hormonal contraceptives containing estradiol 93
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 93
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 93
Reply to: Comment on 'Season of birth influences the timing of menopause' [7] 93
Vaginal atrophy across the menopausal age: results from the ANGEL study 93
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 92
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 92
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 92
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 92
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data 92
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 91
Integrated Clinical Pathways in vaginal and caesarean delivery: effect analysis 2016-2017, Italy 91
Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance tests with different sampling frequency, oral glucose tolerance test or fasting 90
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 89
Recommendations for contraception in women with diabetes. AMD-SIC position paper 89
Season of birth influences the timing of menopause 88
Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen 88
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 88
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 87
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 87
[Evolution and future of contraception.] 87
Small fetal thymus and adverse obstetrical outcome: a systematic review and a meta-analysis 87
Kava-Kava administration reduces anxiety in perimenopausal women. 87
Oral contraceptives and insulin sensitivity 86
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women 86
Is voluntary abortion a seasonal disorder of mood? 86
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women. 86
Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study 86
Seasonal onset of the menopause 85
Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study. 84
Ovary Cystadenofibroma Associated with Didelphys Uterus in a Teenager: Conservative Laparoscopic Management 84
Interplay between maternal weight and seasons in determining the secondary sex ratio of human offspring 84
Medical and patient attitude towards vaginal atrophy: the AGATA study 84
The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study 84
Acupuncture or phy(F)itoestrogens vs. (E)strogen plus progestin on menopausal symptoms. A randomized study 84
Totale 10.499
Categoria #
all - tutte 36.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.439


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.494 0 0 0 0 0 0 0 0 0 253 774 467
2019/20204.137 237 183 177 673 361 675 507 453 385 179 90 217
2020/20212.803 156 238 173 382 304 370 172 237 226 92 268 185
2021/20221.368 92 101 124 93 33 96 98 54 29 210 231 207
2022/20231.930 181 104 19 256 211 587 6 140 276 24 63 63
2023/2024396 113 55 12 10 66 50 7 39 37 7 0 0
Totale 13.839